Leucovorin, Jeffrey Epstein, Novo, FDA: Readout Newsletter

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
Good morning. We’ve got a lot of news and deep dives today, so let’s get straight to it.
A top VC helped Epstein’s friend make a comeback
The biotech industry appeared to distance itself from investor Boris Nikolic after his friendship with Jeffrey Epstein came to light in 2019. But in the following years, one of the most influential biotech venture capitalists, Alexis Borisy, quietly shepherded a comeback for Nikolic, my colleague Damian Garde reports in a new exclusive.
STAT+ Exclusive Story
Already have an account? Log in
This article is exclusive to STAT+ subscribers
Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.
Already have an account? Log in
Individual plans
Group plans
View All Plans
To read the rest of this story subscribe to STAT+.
Subscribe




